Owens & Minor (NYSE:OMI) Issues Earnings Results, Beats Estimates By $0.02 EPS

Owens & Minor (NYSE:OMI) announced its quarterly earnings results on Friday. The company reported $0.55 EPS for the quarter, beating the consensus estimate of $0.53 by $0.02, Zacks reports. The company had revenue of $2.70 billion for the quarter, compared to analyst estimates of $2.68 billion. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The firm’s revenue was up 1.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.69 earnings per share. Owens & Minor updated its FY25 guidance to $1.60-1.85 EPS and its FY 2025 guidance to 1.600-1.850 EPS.

Owens & Minor Stock Performance

OMI traded up $2.85 during trading on Friday, reaching $9.74. The company’s stock had a trading volume of 8,904,269 shares, compared to its average volume of 1,525,674. The company has a market capitalization of $751.04 million, a price-to-earnings ratio of -14.88, a price-to-earnings-growth ratio of 0.20 and a beta of 0.48. The company’s fifty day moving average price is $11.57 and its 200-day moving average price is $13.30. Owens & Minor has a 52-week low of $6.07 and a 52-week high of $28.35. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09.

Wall Street Analyst Weigh In

A number of research firms recently commented on OMI. UBS Group dropped their target price on shares of Owens & Minor from $25.00 to $13.00 and set a “buy” rating on the stock in a research report on Thursday, February 13th. Barclays dropped their price objective on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 5th. Citigroup reduced their target price on Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a report on Tuesday, November 5th. Finally, Robert W. Baird dropped their price target on Owens & Minor from $14.00 to $10.00 and set a “neutral” rating on the stock in a research note on Tuesday. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat, Owens & Minor has an average rating of “Hold” and a consensus target price of $14.92.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.